← Back to Search

Medication-Assisted Therapies for Opioid Use Disorder (ExMAT CA Trial)

Led By Frederick L Altice, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aim 3: 18 years or older, Authorized as a professional to work at an OAT delivery site
Focus Groups (OAT delivery staff): 18 years or older, Currently working as an OAT delivery professional at an OAT delivery site
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights

ExMAT CA Trial Summary

This trial will study the best way to rapidly scale-up opioid agonist therapies in Central Asia to prevent HIV infections in people who inject drugs and their partners.

Who is the study for?
This trial is for adults with opioid dependence in Central Asia, specifically those who inject drugs and are either new to opioid agonist therapy (OAT) or have been on OAT for less than 90 days. It includes both individuals seeking treatment and professionals involved in delivering OAT.Check my eligibility
What is being tested?
The study tests the NIATx strategy, aiming to expand OAT programs effectively across Kazakhstan, Kyrgyzstan, and Tajikistan. The goal is to prevent HIV among people who inject drugs by improving addiction treatments using the EPIS framework.See study design
What are the potential side effects?
Since this trial focuses on implementing a treatment strategy rather than a specific medication, it does not directly involve medical side effects. However, participants may experience various reactions based on their individual responses to OAT.

ExMAT CA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am over 18 and authorized to work at an opioid treatment program.
I am over 18 and work in opioid addiction treatment.
I am over 18 and work in opioid addiction treatment.
I am 18 or older, have opioid dependence, and am new to or have been on opioid addiction treatment for less than 90 days.

ExMAT CA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
OAT Census
OAT Census per Oblast
Secondary outcome measures
Dropout per Oblast
New Patients
+1 more

ExMAT CA Trial Design

1Treatment groups
Experimental Treatment
Group I: NIATx ModelExperimental Treatment1 Intervention
Receiving NIATx Coaching

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,735,628 Total Patients Enrolled
AIDS Foundation East-West (AFEW) KyrgyzstanUNKNOWN
Institute for International Health and EducationUNKNOWN

Media Library

NIATx Clinical Trial Eligibility Overview. Trial Name: NCT05579470 — N/A
Opioid Use Disorder Research Study Groups: NIATx Model
Opioid Use Disorder Clinical Trial 2023: NIATx Highlights & Side Effects. Trial Name: NCT05579470 — N/A
NIATx 2023 Treatment Timeline for Medical Study. Trial Name: NCT05579470 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently underway for this experiment?

"According to clinicaltrials.gov, this particular medical trial is not presently accepting candidates for participation. Having first been published on January 1st 2023 and last edited October 10th 2022, the study has yet to resume recruitment efforts. However, there are currently 292 other studies actively recruiting patients right now."

Answered by AI

What is the ultimate aim of this clinical trial?

"This medical study will have a 36 month duration, during which the primary outcome of interest is OAT Census per Oblast. Other secondary outcomes include New Patients (being Total number of newly enrolled patients into OAT services, per country), Dropout per Oblast (Total number of patients dropping out of OAT services, per oblast) and New Patients Per Oblast (Total number of newly enrolled patients into OAT services, per oblast)."

Answered by AI

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
Columbia University Global Health Research Center of Central Asia
~600 spots leftby Dec 2026